Symptomatic therapy in multiple sclerosis: Big pharma should do more - NO

Mult Scler. 2015 Jul;21(8):978-9. doi: 10.1177/1352458515587930. Epub 2015 Jun 17.
No abstract available

Keywords: Symptomatic therapy; multiple sclerosis.

MeSH terms

  • Clinical Trials as Topic
  • Drug Industry / trends*
  • Drug Repositioning
  • Humans
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy